U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA604231 ID: 604231

Tumour kinome re-wiring governs resistance to palbociclib in estrogen receptor positive breast cancers

Combination of CDK4/6 inhibitors and endocrine therapy improves clinical outcome

in advanced estrogen receptor (ER)-positive breast cancer, however relapse is

inevitable. More...

AccessionPRJNA604231
Data TypeRaw sequence reads
ScopeMultispecies
PublicationsPancholi S et al., "Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities.", Oncogene, 2020 Jun;39(25):4781-4797
SubmissionRegistration date: 31-Jan-2020
Institute of Cancer Research
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Sequence data
SRA Experiments14
Publications
PubMed1
PMC1
Other datasets
BioSample14
SRA Data Details
ParameterValue
Data volume, Gbases130
Data volume, Mbytes51366

Supplemental Content

Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Support Center